ADGRF5 and breast carcinoma: As regards the other two miRNAs of the signature, miR-511-5p was reported tofunction as a tumor suppressor in colorectal cancer by directly targeting GPR116 [34], while miR-598-3p was found to be downregulated in serum samples from breast cancer patients compared to healthy individuals [35].